These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15652887)

  • 21. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection.
    Ganesh A; Goswami S; Chattopadhyay R; Chakraborty C; Chaudhury K; Chakravarty BN
    Fertil Steril; 2009 Apr; 91(4):1018-22. PubMed ID: 18359023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J;
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati ; Shibahara H; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rate at which serum total beta-subunit human chorionic gonadotropin increases after embryo transfer is a predictor of the viability of pregnancy and an identifier of determinants of pregnancy.
    Stone BA; Vargyas JM; Ringler GE; March CM; Marrs RP
    Fertil Steril; 2006 Dec; 86(6):1626-33. PubMed ID: 17081527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome.
    Hughes EG; Robertson DM; Handelsman DJ; Hayward S; Healy DL; de Kretser DM
    J Clin Endocrinol Metab; 1990 Feb; 70(2):358-64. PubMed ID: 2298853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of rescue in vitro fertilization converted from high-response gonadotropin intrauterine insemination cycles in terms of implantation and pregnancy rates as compared with matched controls.
    Haydardedeoglu B; Bagis T; Simsek E; Cok T; Hacivelioglu SO; Erkanli S
    Fertil Steril; 2009 Jul; 92(1):137-42. PubMed ID: 18692785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
    Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders.
    Bai X; Zhang Y; Liu S; Qu D; Su H; Ren H; Li Y
    Gynecol Endocrinol; 2017 Jun; 33(6):452-457. PubMed ID: 28277137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate ovarian follicular status does not prevent the decrease in pregnancy rates associated with high sperm DNA fragmentation.
    Frydman N; Prisant N; Hesters L; Frydman R; Tachdjian G; Cohen-Bacrie P; Fanchin R
    Fertil Steril; 2008 Jan; 89(1):92-7. PubMed ID: 17482180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
    Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
    Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A; Estévez González S; Carballo Mondragón E
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
    Berkkanoglu M; Isikoglu M; Arici F; Ozgur K
    Fertil Steril; 2008 Dec; 90(6):2112-5. PubMed ID: 18177864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.